• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肠道肽载体相对结合亲和力的分子机制。三种血管紧张素转换酶抑制剂的比较:依那普利、依那普利拉和赖诺普利。

Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril.

作者信息

Swaan P W, Stehouwer M C, Tukker J J

机构信息

Department of Pharmaceutics, Utrecht Institute of Pharmaceutical Sciences (UIPS), University of Utrecht, The Netherlands.

出版信息

Biochim Biophys Acta. 1995 May 24;1236(1):31-8. doi: 10.1016/0005-2736(95)00030-7.

DOI:10.1016/0005-2736(95)00030-7
PMID:7794953
Abstract

The affinity of three substrates for the intestinal peptide carrier is explained based on their three-dimensional (3D) structural data. The kinetic transport parameters of three ACE-inhibitors, enalapril, enalaprilat, and lisinopril, have been determined in an in vivo system using rat intestine. The observed kinetic transport parameters (+/- asymptotic standard error) of enalapril are: 0.81 (+/- 0.23) mM, 0.58 (+/- 0.37) mumol/h per cm2, and 0.56 (+/- 0.04) cm/h for the half-maximal transport concentration (KT), the maximal transport flux (Jmax) and the passive permeability constant (Pm). Enalaprilat was transported by passive diffusional with a Pm of 0.51 (+/- 0.04) cm/h. For lisinopril the kinetic transport parameters were 0.38 (+/- 0.19) mM, 0.12 (+/- 0.07) mumol/h per cm2, and 0.18 (+/- 0.02) cm/h for KT, Jmax, and Pm, respectively. The affinity of the ACE-inhibitors for the intestinal peptide carrier has been evaluated based on their ability to inhibit the transport rate of cephalexin. The inhibition constants (Ki) of enalapril, enalaprilat and lisinopril were 0.15, 0.28 and 0.39 mM, respectively. 3D structural analysis of lisinopril using molecular modelling techniques reveals that intramolecular hydrogen bond formation is responsible for decreased carrier affinity.

摘要

基于三种底物的三维(3D)结构数据,解释了它们对肠道肽载体的亲和力。使用大鼠肠道在体内系统中测定了三种ACE抑制剂(依那普利、依那普利拉和赖诺普利)的动力学转运参数。依那普利观察到的动力学转运参数(±渐近标准误差)为:半数最大转运浓度(KT)为0.81(±0.23)mM,最大转运通量(Jmax)为0.58(±0.37)μmol/h·cm²,被动渗透常数(Pm)为0.56(±0.04)cm/h。依那普利拉通过被动扩散转运,Pm为0.51(±0.04)cm/h。对于赖诺普利,KT、Jmax和Pm的动力学转运参数分别为0.38(±0.19)mM、0.12(±0.07)μmol/h·cm²和0.18(±0.02)cm/h。基于ACE抑制剂抑制头孢氨苄转运速率的能力,评估了它们对肠道肽载体的亲和力。依那普利、依那普利拉和赖诺普利的抑制常数(Ki)分别为0.15、0.28和0.39 mM。使用分子建模技术对赖诺普利进行的3D结构分析表明,分子内氢键的形成导致载体亲和力降低。

相似文献

1
Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril.与肠道肽载体相对结合亲和力的分子机制。三种血管紧张素转换酶抑制剂的比较:依那普利、依那普利拉和赖诺普利。
Biochim Biophys Acta. 1995 May 24;1236(1):31-8. doi: 10.1016/0005-2736(95)00030-7.
2
Structure-transport relationship for the intestinal small-peptide carrier: is the carbonyl group of the peptide bond relevant for transport?肠道小肽载体的结构-转运关系:肽键的羰基与转运有关吗?
Pharm Res. 1999 Jan;16(1):62-8. doi: 10.1023/a:1018866611555.
3
Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine.
Biochem Pharmacol. 1994 Mar 29;47(7):1121-6. doi: 10.1016/0006-2952(94)90382-4.
4
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.依那普利对兔肾刷状缘膜囊泡中甘氨酰肌氨酸转运的竞争性抑制:血管紧张素转换酶抑制剂与高亲和力H⁺/肽同向转运体的相互作用
Pharm Res. 1999 May;16(5):609-15. doi: 10.1023/a:1018847818766.
5
Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats.
Drug Metab Dispos. 1988 May-Jun;16(3):392-6.
6
Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.血管紧张素转换酶(ACE)抑制剂在人肠上皮(Caco-2)细胞中的转运。
Br J Pharmacol. 1995 Mar;114(5):981-6. doi: 10.1111/j.1476-5381.1995.tb13301.x.
7
Radioimmunoassay for the quantitation of lisinopril and enalaprilat.赖诺普利和依那普利拉定量的放射免疫测定法。
J Pharm Sci. 1986 May;75(5):512-6. doi: 10.1002/jps.2600750518.
8
Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.卡托普利、赖诺普利和依那普利对绵羊组织中血管紧张素转换酶的抑制作用。
Indian J Biochem Biophys. 1997 Dec;34(6):524-8.
9
A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.赖诺普利、依那普利拉和卡托普利与血管紧张素转换酶结合的量热研究。
Biophys Chem. 2004 Oct 1;111(2):183-9. doi: 10.1016/j.bpc.2004.05.011.
10
Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852.
J Pharm Sci. 1989 Dec;78(12):995-8. doi: 10.1002/jps.2600781205.

引用本文的文献

1
The influence of dietary peptide inhibitors of angiotensin-converting enzyme on the hypotensive effects of enalapril.血管紧张素转换酶饮食肽抑制剂对依那普利降压作用的影响。
J Pharm Health Care Sci. 2015 Jun 3;1:17. doi: 10.1186/s40780-015-0018-3. eCollection 2015.
2
Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney.免疫细胞化学法检测 bestatin 及其在大鼠肠和肾药物蓄积研究中的应用。
J Mol Histol. 2011 Dec;42(6):589-96. doi: 10.1007/s10735-011-9365-z. Epub 2011 Oct 18.
3
Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
依那普利对兔肾刷状缘膜囊泡中甘氨酰肌氨酸转运的竞争性抑制:血管紧张素转换酶抑制剂与高亲和力H⁺/肽同向转运体的相互作用
Pharm Res. 1999 May;16(5):609-15. doi: 10.1023/a:1018847818766.
4
Structure-transport relationship for the intestinal small-peptide carrier: is the carbonyl group of the peptide bond relevant for transport?肠道小肽载体的结构-转运关系:肽键的羰基与转运有关吗?
Pharm Res. 1999 Jan;16(1):62-8. doi: 10.1023/a:1018866611555.